New collaboration focused on advancing therapies for rare genetic disorders
(October 16, 2024) Guardian Research Network, Inc. (GRN) announced the recent addition of Greenwood Genetic Center (GGC), a leading provider of genetic care and testing, into its national nonprofit consortium of healthcare organizations. The strategic collaboration will bolster GRN’s mission to accelerate the discovery of treatments and improve patient care, particularly for those with rare genetic disorders.
The Greenwood Genetic Center’s ongoing commitment in providing compassionate patient care for children and families impacted by genetic disorders has led the Center’s mission for five decades. In that time, the Center has amassed significant longitudinal clinical information and genetic testing data on patients with rare diseases. By joining forces with other GRN members, the combined impact of this data will be transformational in Greenwood Genetic Center’s ability to not only provide accurate diagnoses but also advance clinical trial participation and ultimately accelerate discovery and development of effective therapies for rare orphan diseases.
“Greenwood Genetic Center is excited to partner with so many cutting-edge healthcare organizations through GRN in harnessing the power of collaborative data to improve access to clinical trials and effective therapies for patients with both rare and common genetic disorders,” said Steve Skinner, MD, President and CEO of GGC. “We are proud to join this South Carolina-led network in enhancing state-of-the-art care for patients across the US.”
By joining GRN, Greenwood Genetic Center strengthens its position within a powerful and committed nationwide network of healthcare systems to collaboratively harness big data and apply AI to further enhance medical research. Together, the nonprofit organizations will leverage this data to unlock new insights and support the development of groundbreaking therapies for both rare and common genetic disorders.
“The Greenwood Genetic Center’s long and distinguished dedication to the advancement of medical science and our understanding of systems biology aligns beautifully with our goal to harness data for the advancement of healthcare,” comments Bruce Holstien, CEO of GRN. “Greenwood Genetic Center’s expertise in rare and common disease diagnosis and its molecularly rich longitudinal dataset will contribute significantly to GRN’s efforts to expand clinical trial access and develop much-needed therapies for underserved populations.”
As GRN’s consortium grows, its Real World Data (RWD) continues to shape the future of healthcare by driving innovations that improve outcomes for millions of patients across the country.
About Guardian Research Network
Guardian Research Network, Inc.®, a 501(c)(3) nonprofit organization, is a nationwide consortium comprised of community healthcare organizations focused on advancing technology to accelerate cures and care improvements. GRN works within the life sciences industry and with its health system members to increase participation in data-driven research, optimize therapeutic and diagnostic studies and employ real world data to improve patient access to precision medicines in underserved communities. For more information, visit www.guardianresearch.org.